Global Health Limited (ASX:GLH)
Market Cap | 5.80M |
Revenue (ttm) | 8.95M |
Net Income (ttm) | -867.71K |
Shares Out | 58.57M |
EPS (ttm) | -0.01 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 35,544 |
Average Volume | 21,357 |
Open | 0.1100 |
Previous Close | 0.0990 |
Day's Range | 0.0990 - 0.1100 |
52-Week Range | 0.0900 - 0.1600 |
Beta | 0.08 |
RSI | 32.31 |
Earnings Date | May 23, 2025 |
About Global Health
Global Health Limited provides digital health solutions for the healthcare industry in Australia. The company offers saas and software applications for electronic medical records, patient administration systems, practice management systems, clinical records, secure connectivity, patient engagement platforms, and consumer health records. It is also involved in the development, sale, and support of the application software for the healthcare sector; and development of system integration software that enables data to be exchanged within an enterpr... [Read more]
Financial Performance
In 2024, Global Health's revenue was 8.66 million, an increase of 10.75% compared to the previous year's 7.82 million. Losses were -1.31 million, -83.71% less than in 2023.
Financial StatementsNews

Global Health shares rise over 2% as Medanta evaluates land offer for Assam hospital
Shares of Global Health Ltd, the operator of Medanta hospitals, jumped 2.35% to ₹1,224.05 in Monday’s trade after the company disclosed that it has received a formal offer from the Assam Electricity G...

Medanta receives offer from Assam govt to set up super speciality hospital in Guwahati
Global Health Limited, which operates under the brand name Medanta, has announced that it has received a formal offer from Assam Electricity Grid Corporation Limited (AEGCL), a government entity, for ...

Global Health shares surge over 4% as EBITDA jumps 11% YoY in Q3
Global Health Ltd. saw its shares jump more than 4% after reporting robust Q3 earnings, reflecting steady growth in revenue and profitability. As of 9:31 AM, the shares were trading 4.70% higher at Rs...

Jefferies maintains Hold call on Medanta, target of Rs 1,170
Jefferies has maintained a 'Hold' rating on Global Health Limited (Medanta), with a target price of ₹1,170.

Global Health (Medanta) shares rise over 2% as Medanta announces new 750-bed hospital in New Delhi
As of 9:55 am, Global Health Limited (Medanta) shares were trading 1.96% higher at ₹1,095.15 on the NSE, following the announcement of a new 750-bed super-speciality hospital in New Delhi. This expans...

Medanta to operate 750-bed super speciality hospital in Delhi, commits ₹600 crore capex
Medanta, a prominent healthcare provider under Global Health Limited, has announced a new venture to operate and manage a 750-bed super speciality hospital in New Delhi. This expansion marks another s...

Global Health (Medanta) shares surge over 5% in morning trade
Global Health Limited, operating under the brand name Medanta, is witnessing a significant uptick in its stock price during early trading hours today. Key highlights: Current Trading: Stock Price: ₹1,...